ChemBioChem
ChemBioChem
3 years ago

Redirecting Killer T Cells through Incorporation of Azido Sugars for Tethering Ligands

Redirecting Killer T Cells through Incorporation of Azido Sugars for Tethering Ligands
Demin Zhou, Weiling Wang, Qing Xia, Chuanling Zhang, Xinshan Ye, Lihe Zhang, Ziwei Zhang, Sulong Xiao, Zhiying Zhao
The cover picture shows a chemical approach to generating tumor-specific cytotoxic T cells by using Ac4ManNAz as a small-molecule engager. T cells were first cultured in Ac4ManNAz and then incubated with Alexa Fluor 488 dibenzocyclooctynol (DIBO) to achieve the tumor-specific targeting. These tumor-specific cytotoxic T cells amplified and secreted cytokines after interaction with tumor cells. This method poses no risk of insertional mutagenesis, thereby making it feasible as a safe approach for the production of tumor-specific cytotoxic T cells in cancer immunotherapy. More importantly, the displayed azido moiety and the tethered ligands remain stable only for a few days, thus allowing the control of cytotoxicity and cytokine release. This chemical approach provides a facile platform for the rational design of tumor-specific cytotoxic T cells for targeted immunotherapy. More information can be found in the communication by Q. Xia, D. Zhou et al..

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/cbic.201700549

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.